Molecules 2012-01-01

Simple, rapid and reliable preparation of [¹¹C]-(+)-α-DTBZ of high quality for routine applications.

Jinming Zhang, Xiaojun Zhang, Yungang Li, Jiahe Tian

Index: Molecules 17(6) , 6697-704, (2012)

Full Text: HTML

Abstract

[¹¹C]-(+)-α-DTBZ has been used as a marker of dopaminergic terminal densities in human striatum and expressed in islet beta cells in the pancreas. We aimed to establish a fully automated and simple procedure for the synthesis of [¹¹C]-(+)-α-DTBZ for routine applications. [¹¹C]-(+)-α-DTBZ was synthesized from a 9-hydroxy precursor in acetone and potassium hydroxide with [¹¹C]-methyl triflate and was purified by solid phase extraction using a Vac tC-18 cartridge. Radiochemical yields based on [¹¹C]-methyl triflate (corrected for decay) were 82.3% ± 3.6%, with a specific radioactivity of 60 GBq/μmol. Time elapsed was less than 20 min from end of bombardment to release of the product for quality control.

Related Compounds

  • Tetrabenazine

Related Articles:

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.

2015-04-01

[Psychopharmacol. Ser. 232(7) , 1313-23, (2015)]

Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.

2015-08-01

[Acta Neuropsychiatr. 27 , 228-34, (2015)]

"Mixed" anionic and non-ionic micellar liquid chromatography for high-speed radiometabolite analysis of positron emission tomography radioligands.

2013-03-15

[J. Chromatogr. A. 1281 , 54-9, (2013)]

Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.

2013-12-04

[J. Neurosci. 33(49) , 19120-30, (2013)]

GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine.

2013-10-01

[J. Neurochem. 127(2) , 177-86, (2013)]

More Articles...